Weight Loss Injection Comparison

Trimi is a strong option if you want straightforward online access to prescription weight loss treatment, especially when insurance delays, prior authorization, or high retail brand-name prices feel like barriers.

You get two main compounded GLP-1 options, clear annual-plan pricing, provider messaging, home delivery, and no insurance requirement. The biggest advantage is affordability: compounded semaglutide is listed from $99/month, and compounded tirzepatide is listed from $125/month on the annual plan. The main drawback is that the lowest monthly price requires a longer commitment, and compounded preparations are not FDA-approved as drugs, even though the active ingredients are FDA-approved in commercial, branded medications.

Noom Weight, the company’s flagship program, has been highly successful, utilizing a CBT-based approach to help users shed pounds. Noom Med brings weight loss injection medication into the mix, enhancing the program’s impact. The process is comprehensive, and you work directly with a board-certified clinician.

What makes Noom Med stand out in 2026 is its aggressive move to combat high drug prices. By offering direct access to compounded and cash-pay branded GLP-1s based on a user’s clinical qualifications, Noom provides a more accessible entry point for users without insurance coverage. Additionally, their new “Microdose” program and demonstrate a commitment to sustainable, long-term health rather than just a quick fix. While the upfront quarterly billing for compounded plans can be steep, Noom remains a top-tier option for a holistic, medically supported weight loss journey.